SEC Form 4 · accession 0001437749-17-006036
BIOLARGO, INC. · BLGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John S. Runyan
Director
Period of report
Mar 31, 2017
Accepted (ET)
Apr 4, 2017 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000880242
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $0.50 | Mar 31, 2017 | A | 37,500 | A | Mar 31, 2017 | Mar 31, 2027 | Common Stock | 37,500 | 907,219 | D |
Explanation of responses
- F1This Option was issued to Reporting Person as payment for $18,750 in fees due to Reporting Person by Issuer in exchange for services on its board of directors pursuant to a plan adopted by the Issuer's Board to retire outstanding accounts payable.